UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: SandimmunNeoral25mgkapselmjuk-SE-PLC-MPD-BBDL

Sandimmun Neoral 25 mg kapsel, mjuk

MPID: SE-100003469-00012308
EURDID: 745

Full name: Sandimmun Neoral 25 mg kapsel, mjuk

- Scientific name part: Sandimmun Neoral

- Strength part: 25 mg

- Pharmaceutical dose form part: kapsel, mjuk

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Capsule, soft

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000096879 ciclosporin

Marketing Authorisation 1 of 1

Authorisation number: 12308

Region: Kingdom of Sweden

Marketing authorisation holder: Novartis Sverige AB

Identifier:

  • LOC-100020269

Status: Valid (1994-09-09)

Package 1 of 1

PCID:

Description:
Blister, 50 kapslar

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 50 Capsule

Package: 1 Box (Cardboard)

Containing:

Package: 5 Blister (Aluminium) (PolyVinyl Chloride) (PolyAmide)

Containing: 10 Capsule

Manufactured Item

Dose form: Capsule, soft

Unit of presentation: Capsule

Ingredient

Role: Active

Substance: Ciclosporin

Presentation strength: 25 milligram(s) / 1 Capsule

Reference strength:
Ciclosporin 25 milligram(s) / 1 Capsule

Administrable Product (1 of 1)

Dose form: Capsule, soft

Unit of presentation:

Route of administration:

  • Oral use

Ingredients:

Ingredient

Role: Active

Substance: Ciclosporin

Presentation strength: 25 milligram(s) / 1 Capsule

Reference strength:
Ciclosporin 25 milligram(s) / 1 Capsule